ADDvise receives allocation decision worth approximately EUR 2.4 million

19-07-2022   Regulatory press release

ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from Helsinki University Hospital in Finland regarding digital x-ray equipment with a total value of approximately EUR 2.4 million. Installations are expected to take place during the year 2022 and 2023.

In accordance with Finnish procurement law the allocation decision can be appealed directly to the procuring unit within two weeks from the date of the allocation decision.  
 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se


Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 19 July 2022 at 13:15 CEST.
 

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

 

Latest press releases

ADDvise signs Letter of Intent to acquire CliniChain Holding B.V.

Regulatory

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of CliniChain Holding B.V. (”CliniChain”) regarding an acquisition of 100 percent of the shares in CliniChain. CliniChain is a fast-growing international medtech equipment provider for clinical studies. The company offers tailored rental and purchase solutions of medtech equipment that are adapted to…

ADDvise receives order worth USD 640,000

Regulatory

ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Hortman Health Care Investment LLC, an investment company in the private healthcare sector, based in the United Arab Emirates. The order is worth approximately USD 640,000 and involves design, supply, and installation of a stem cell laboratory for a clinic in Dubai, United…

Interim report January 1 – June 30, 2022

Regulatory

April-June 2022 Orders received for the period was SEK 260.9 million (122.8), an increase of 112.5 %. Organic growth was 22.3 %. Net revenue for the period was SEK 231.9 million (117.6), an increase of 97.1 %. Organic growth was 3.1 %. Adjusted EBITDA for the period was SEK 31.8 million (15.5) EBITDA for the…

ADDvise receives allocation decision worth approximately EUR 2.4 million

Regulatory

ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from Helsinki University Hospital in Finland regarding digital x-ray equipment with a total value of approximately EUR 2.4 million. Installations are expected to take place during the year 2022 and 2023. In accordance with Finnish procurement law the allocation decision can be appealed…